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We have shown previously that partial inhibition of
the cardiac myocyte Na1/K1-ATPase activates signal
pathways that regulate myocyte growth and growth-
related genes and that increases in intracellular Ca21
concentration ([Ca21]i) and reactive oxygen species
(ROS) are two essential second messengers within these
pathways. The aim of this work was to explore the rela-
tion between [Ca21]i and ROS. When myocytes were in a
Ca21-free medium, ouabain caused no change in [Ca21]i,
but it increased ROS as it did when the cells were in a
Ca21-containing medium. Ouabain-induced increase in
ROS also occurred under conditions where there was
little or no change in [Na1]i. Exposure of myocytes in
Ca21-free medium to monensin did not increase ROS.
Increase in protein tyrosine phosphorylation, an early
event induced by ouabain, was also independent of
changes in [Ca21]i and [Na
1]i. Ouabain-induced genera-
tion of ROS in myocytes was antagonized by genistein, a
dominant negative Ras, and myxothiazol/diphenylenei-
odonium, indicating a mitochondrial origin for the Ras-
dependent ROS generation. These findings, along with
our previous data, indicate that increases in [Ca21]i and
ROS in cardiac myocytes are induced by two parallel
pathways initiated at the plasma membrane: One being
the ouabain-altered transient interactions of a fraction
of the Na1/K1-ATPase with neighboring proteins (Src,
growth factor receptors, adaptor proteins, and Ras)
leading to ROS generation, and the other, inhibition of
the transport function of another fraction of the Na1/K1-
ATPase leading to rise in [Ca21]i. Evidently, the gene
regulatory effects of ouabain in cardiac myocytes re-
quire the downstream collaborations of ROS and
[Ca21]i.
Ouabain and related cardiac glycosides are specific inhibi-
tors of Na1/K1-ATPase, the enzyme that carries out the active
transport of Na1 and K1 across the plasma membrane of most
animal cells (1, 2). In the heart, interaction of cardiac glycoside
drugs with the Na1/K1-ATPase regulates contractility. It is
now widely accepted that partial inhibition of the cardiac myo-
cyte Na1/K1-ATPase by a cardiac glycoside causes a modest
increase in [Na1]i,
1 which in turn affects the plasma membrane
Na1/Ca21-exchanger, leading to a significant increase in
[Ca21]i and in the force of contraction (3–5). This positive
inotropic effect of cardiac glycosides is the basis of the major
therapeutic use of these drugs in the management of congestive
heart failure (3–6).
The cumulative findings of our laboratories during the past
few years (7–12) have revealed the following previously un-
known effects of ouabain on cardiac myocytes: 1) The same
nontoxic concentrations of ouabain that cause partial inhibi-
tion of Na1/K1-ATPase and increase in [Ca21]i also stimulate
the nonproliferative growth (hypertrophy) of the myocytes and
regulate the transcription of a number of growth-related genes.
2) These ouabain effects involve the activation of multiple
signal transduction pathways, including the activation of Src
kinase and tyrosine phosphorylation of the epidermal growth
factor receptor and other proteins, followed by the activation of
Ras and the Ras/Raf/MEK/MAPK cascade. 3) The gene regula-
tory actions of ouabain, like its classical effect on cardiac con-
tractility, are dependent on the net influx of Ca21 and rise in
[Ca21]i, indicating that the latter is a shared second messenger
for the ouabain effects on cardiac contractility and growth. 4)
Ouabain’s hypertrophic and gene regulatory effects also in-
volve intracellularly generated ROS as essential second mes-
sengers. Significantly, our studies also showed (11) that anti-
oxidants block the ouabain-induced ROS generation but not the
ouabain-induced inhibition of the Na1/K1-ATPase and in-
crease in [Ca21]i, raising important questions regarding the
relationship between the two essential second messengers of
ouabain interaction with the cardiac Na1/K1-ATPase. For the
clarification of the mechanism of the signal transducing func-
tion of the Na1/K1-ATPase, it seemed necessary to determine
if the two second messengers, [Ca21]i and ROS, are generated
sequentially or in parallel, and the order of their generations.
The primary aim of the studies reported here was the resolu-
tion of these and related issues. A preliminary account of por-
tions of this work has been presented (13).
EXPERIMENTAL PROCEDURES
Cell Preparation and Culture—The same protocol was used to pre-
pare and culture neonatal ventricular myocytes as described in our
previous work (7). In short, myocytes from 1-day-old Harlan Sprague-
Dawley rats were isolated and purified on Percoll gradients. In a me-
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dium containing four parts of DMEM and one part Medium 199 (Life
Technologies, Inc.), penicillin (100 units/ml), streptomycin (100 mg/ml),
and 10% fetal bovine serum, myocytes were cultured for 24 h at 37 °C in
humidified air with 5% CO2. After 24 h, the myocytes were serum-
starved for 48 h at which time all experiments were performed. Some of
the experiments were done in a nominally Ca21-free medium, which
was prepared to contain the same components as DMEM except that
calcium salts were omitted and 0.1 mM EGTA was added to the medium.
As we previously reported, incubation of cardiac myocytes in this me-
dium had no significant effect on cell viability for the experimental
durations used here (7). Immunofluorescence staining with a myosin
heavy chain antibody showed that the cultures contained more than
95% myocytes.
Fluorescence Microscopic Measurements of [Ca21]i, [Na
1]i, and
ROS—Myocytes were cultured on glass coverslips. [Ca21]i was meas-
ured by fura-2 as we previously described (7, 11). The fura-2 fluores-
cence was recorded using an Attofluor imaging system (Atto Instru-
ments) at an excitation wavelength of 340/380 nm and at an emission
wavelength of 505 nm. Under each experimental condition time-aver-
aged signals were obtained from about 40 single cells. [Ca21]i was
calculated based on the fluorescence ratio and the Ca21calibration
curve (7, 11). To measure [Ca21]i transients, myocytes were loaded with
10 mM indo-1-AM for 30 min. Indo-1 fluorescence was recorded using a
microscope-based fluorescence system (Photon Technology Interna-
tional, Monmouth Junction, NJ). The probe was excited at 365 nm, and
fluorescence emitted at 405 and 485 nm was recorded. The emission
ratio was recorded at a speed of 60 Hz. [Na1]i was determined by the
fluorescent probe SBFI. Myocytes were loaded with 5 mM SBFI-AM and
0.075% Pluronic, a surfactant, for 30 min at 37 °C and washed. SBFI
fluorescence was recorded as in the case of the fura-2 signal at an
excitation wavelength of 340/380 nm and at an emission wavelength of
505 nm. Calibration of [Na1]i was done by modifications of established
procedures (14, 15). Briefly, SBFI-loaded myocytes were incubated in a
solution containing 10 mM monensin, a Na1-specific ionophore. Calibra-
tion solutions contained 0–80 mM Na1. [Na1]i in control and treated
myocytes was then calculated based on this calibration curve. Substi-
tution of 10 mM gramicidin for monensin caused no significant change in
the calibration curve within the range of 0–80 mM Na1. Intracellular
ROS production in cells loaded with 10 mM CM-DCFH diacetate for 15
min at room temperature in the dark was measured as we previously
described (11). Under each experimental condition, about 15 single
myocytes were imaged with an Attofluor imaging system, and CM-DCF
fluorescence was measured at an excitation wavelength of 480 nm and
an emission wavelength of 520 nm. All the chemicals for these fluores-
cence assays were obtained from Molecular Probes (Eugene, OR).
Measurement of Tyrosine Phosphorylation—Immunoblotting, using
an anti-phosphotyrosine antibody with established specificity (PY99,
Santa Cruz Biotechnology, Santa Cruz, CA), was performed as we
described previously (12). The quantitative comparisons of the intensi-
ties of the bands were also done as described previously (12).
Preparation of Replication-defective Adenovirus Asn17 Ras and Ade-
novirus Infection of Cardiac Myocytes—A replication-defective adenovi-
rus expressing the dominant negative Asn17 Ras was generated, ampli-
fied, purified, and used for the infection of myocytes as we described
previously (10). An identical virus containing the b-galactosidase gene
instead of the Asn17 Ras was used as the control (10).
RESULTS
Effects of Ouabain on ROS and [Ca21]i in Cardiac Myo-
cytes—Our previous data (11) on the differential effects of an
antioxidant on the ouabain-induced increases in [Ca21]i and
ROS suggested that either the ouabain-induced ROS genera-
tion occurred within a pathway parallel to that causing the rise
in [Ca21]i, or that the increased [Ca
21]i led to ROS generation,
but that the antioxidant effect was distal to the rise in [Ca21]i.
To test these alternatives, ouabain effects on intracellular ROS
generation were compared in myocytes incubated in the normal
Ca21-containing culture medium and those incubated in a
Ca21-free culture medium. The ouabain-induced ROS genera-
tion was nearly identical under the two conditions (Fig. 1).
Because it is based on the accepted mechanism of ouabain
action in cardiac myocytes (3–5), ouabain is not expected to
increase [Ca21]i when myocytes are in a Ca
21-free medium;
therefore, the data in Fig. 1 suggest that ROS generation is
independent from increased [Ca21]i. To see if this could be
firmly established, we examined the effects of ouabain on
[Ca21]i and on the spontaneous contractions of the myocytes
exposed to the Ca21-containing and the Ca21-free media. As
noted previously (7, 16, 17), the neonatal rat cardiac myocytes
that are cultured at relatively low densities and serum-starved
(“Experimental Procedures”) are predominantly quiescent; i.e.
most do not contract spontaneously, and some contract with a
low rate. When these myocytes, in a normal Ca21-containing
medium, were exposed to 100 mM ouabain, both the number of
contracting cells and the rate of contractions increased. This is
depicted in Fig. 2 where contractions in a population of cells,
observed under a microscope, were counted before and after the
addition of ouabain. The ouabain-induced increase in the rate
of contraction was also observed when [Ca21]i transients, each
representing a contraction, were monitored with indo-1 in sin-
gle myocytes that were in the normal Ca21-containing medium,
as shown in Fig. 3A for a representative single cell. Ouabain-
induced increase in [Ca21]i was also evident in single cells (Fig.
3A), where diastolic [Ca21]i started to rise 2–3 min after expo-
sure to ouabain. The time-averaged mean of [Ca21]i in cell
populations, placed in the Ca21-containing medium and as-
sayed after 20 min, nearly doubled in response to 100 mM
ouabain as shown in Table I.
When myocytes were placed in the Ca21-free medium and
monitored for beating, no contractions were noted either before
or after the addition of ouabain (Fig. 2). This was also the case
if the cells containing indo-1 were examined for [Ca21]i tran-
sients, as exemplified by the single cell tracing of Fig. 3B,
where no increase in [Ca21]i and no transients were noted after
ouabain addition. When [Ca21]i was measured in a population
of myocytes placed in the Ca21-free medium, ouabain did not
cause a change in [Ca21]i in sharp contrast to the ouabain-
induced doubling of the [Ca21]i in myocytes placed in the Ca
21-
containing medium (Table I). The above data, taken together,
clearly indicate that in the cultured cardiac myocytes used here
ROS generation induced by 100 mM ouabain occurs independent
of the ouabain-induced increase in [Ca21]i and the associated
myocyte contraction.
FIG. 1. Effects of ouabain and monensin on intracellular ROS
production by myocytes incubated in Ca21-containing (control)
and Ca21-free media. Myocytes loaded with CM-DCFH were incu-
bated in the indicated media for 15 min, exposed to 100 mM ouabain or
25 mM monensin, and then measured for CM-DCF fluorescence as
described under “Experimental Procedures.” Each value is the mean 6
S.E. of determinations on 40–60 cells in three to five independent
experiments.
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Lack of Relation of the [Na1]i to the Ouabain-induced ROS
Generation in Myocytes—Based on the established reserve ca-
pacity of Na1/K1-ATPase in various intact heart preparations
and in chick cardiac myocytes (4, 5, 18, 19), the partial inhibi-
tion of Na1/K1-ATPase caused by the highest ouabain concen-
tration (100 mM) used in the present studies was expected to
lead to either no increase or a modest increase in [Na1]i of
these myocytes (see “Discussion”). To see if this were indeed the
case, we determined the effects of 100 mM ouabain on [Na1]i
when myocytes were incubated either in the Ca21-containing
medium or in the Ca21-free medium (Fig. 4). As expected from
previous studies on cardiac myocytes and isolated cardiac mus-
cle preparations (20–22), exposure of the cells to the Ca21-free
medium caused a small increase in [Na1]i prior to the addition
of ouabain (Fig. 4). After the addition of ouabain, there were no
significant changes in [Na1]i during 30 min of incubation in the
Ca21-containing medium, and only at one time point (30 min)
a small but significant increase in [Na1]i of the cells incubated
in the Ca21-free medium was noted (Fig. 4). These findings are
consistent with the degree of inhibition of Na1/K1-ATPase of
these myocytes by 100 mM ouabain (see “Discussion”). Clearly,
comparison of the data in Figs. 1 and 4 argues against the
possibility of a ouabain-induced rise in [Na1]i being responsible
for the increased ROS generation. To see if a large increase in
[Na1]i affects ROS generation, cells incubated in the Ca
21-free
culture medium containing 150 mM Na1 were exposed to mon-
ensin, a Na1-specific ionophore. Monensin did not increase
ROS generation (Fig. 1). This finding and the data of Fig. 4 rule
out increased [Na1]i as a second messenger for the ouabain-
induced ROS generation in these myocytes when ouabain con-
centration is 100 mM or less.
Ouabain-induced Protein Tyrosine Phosphorylation in Myo-
cytes Incubated in a Ca21-free Medium—We have shown that
in neonatal cardiac myocytes ouabain, added to the normal
Ca21-containing culture medium, causes a rapid increase in
protein tyrosine phosphorylation (12). When myocytes were
placed in the Ca21-free medium, ouabain also induced rapid
increases in tyrosine phosphorylation of a number of proteins
(Fig. 5). This result, and the data of Table I and Figs. 3B and 4,
clearly indicate that stimulation of tyrosine phosphorylation by
100 mM ouabain is also not due to changes in [Ca21]i or [Na
1]i.
Although the prominent tyrosine-phosphorylated bands of Fig.
5 seem to be similar to those noted in experiments done in the
FIG. 2. Effects of ouabain on myocyte contractile activity in
Ca21-containing (control) and Ca21-free media. Myocytes were
incubated in the indicated media for 15 min then exposed to 100 mM
ouabain for various times. Five myocytes per dish were randomly cho-
sen, and spontaneous beating was counted under microscope for 30 s at
each time point. A total of 15 cells from three dishes were counted in
each experiment. Each value is the mean 6 S.E. of determinations of 45
cells from three independent experiments. Myocytes exhibited no spon-
taneous beating when incubated in the Ca21-free DMEM (data not
shown).
FIG. 3. Effects of ouabain on [Ca21]i transients in myocytes.
Cells loaded with indo-1 were incubated in either the Ca21-containing
(A) or the Ca21-free (B) medium for 15 min, exposed to 100 mM ouabain
as indicated, and measured for transients as described under “Experi-
mental Procedures.” Each panel is a single cell tracing representative of
those noted in four independent experiments.
TABLE I
Different effects of 100 mM ouabain on [Ca21]i in rat neonatal cardiac
myocytes incubated in Ca21-containing and Ca21-free media
Cells were loaded with fura-2, placed either in the normal Ca21-
containing medium or the Ca21-free medium for 15 min, exposed to
ouabain, and monitored for changes in the fluorescence signals as
indicated under “Experimental Procedures.” The time-averaged mean
of [Ca21]i in cell populations were determined 15–20 min after exposure
to ouabain when [Ca21]i had stabilized.
Incubation medium
[Ca21]i
Control Ouabain-treated
Ca21-containing 109 6 17 219 6 28a
Ca21-free 86 6 8 90 6 12
a p , 0.05 relative to control.
FIG. 4. Time course of the effects of 100 mM ouabain on [Na1]i in
cardiac myocytes. Cells loaded with BSFI were incubated in the
Ca21-containing (control) or the Ca21-free medium for 15 min then
exposed to ouabain for various times. [Na1]i was measured as described
under “Experimental Procedures.” Each value is the mean 6 S.E. of
determinations from 30 different cells in three independent experi-
ments. *p , 0.05, relative to zero time value in Ca21-free medium. At
each time point the value for Ca21-free medium was significantly larger
than the value in the corresponding control (p , 0.05).
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Ca21-containing medium (Figs. 2–5 of Ref. 12) and because we
have not done a thorough comparison of the phosphorylation
patterns obtained in the Ca21-containing and Ca21-free media,
the possibility of the existence of subtle but significant differ-
ences in these patterns cannot be ruled out and remains to be
explored.
Relation of the Ouabain-induced ROS Generation in Myo-
cytes to Protein Tyrosine Phosphorylation and Ras—Because
the ouabain-induced increases in tyrosine phosphorylation and
ROS generation were both found to be independent of increases
in [Ca21]i and [Na
1]i, we explored the relation of the two
ouabain-induced events. Genistein blocked the ouabain-in-
duced ROS production (Fig. 6), suggesting that increased pro-
tein tyrosine phosphorylation, which leads to Ras activation
(12), is required for ROS production. This conclusion could be
questioned, however, due to the possibility of genistein also
being an antioxidant (23). Seeking independent evidence for
the suggested conclusion of the experiments of Fig. 6, we tried
to determine if the ouabain-induced ROS production required
activated Ras. Using procedures that we have used previously
(10), myocytes were transfected with an adenovirus expressing
a dominant negative Ras or a control virus, exposed to ouabain,
and assayed for intracellular ROS. As shown in Fig. 7, ouabain
stimulated ROS production in control myocytes but not in those
expressing the dominant negative Ras, thus indicating that
ROS production is Ras-dependent.
The Sources of the Ouabain-induced ROS—To begin the
identification of the intracellular origin of ROS generated in
response to ouabain, myocytes were preincubated with differ-
ent concentrations of myxothiazol (an inhibitor of ROS gener-
ated in mitochondria) or DPI (an inhibitor of flavoenzymes),
then exposed to ouabain, and monitored for ROS production. In
preliminary experiments (not shown) each compound was
found to inhibit the ROS generation, and the maximally effec-
tive concentrations were found to be 0.6 mM myxothiazol and 10
mM DPI. At these optimal concentrations, each compound
blocked a fraction of the ouabain-induced ROS generation, but
the combination of the two caused complete inhibition of the
ouabain effect (Fig. 8). These data, along with those of Fig. 7,
indicate that ouabain-induced and Ras-dependent ROS origi-
nate, at least in part, from the myocyte mitochondria. Evi-
dently, the ROS-generating pathways that begin at the plasma
membrane Na1/K1-ATPase and are independent of changes in
[Ca21]i and [Na
1]i extend into the mitochondrial matrix.
Ouabain-induced ROS Generation in Cells Other Than Car-
diac Myocytes—Because our recent studies (12) showed that
the ouabain-induced increase in protein tyrosine phosphoryla-
tion occurred in cardiac myocytes and several other cell types,
it was of interest to know the cell type specificity of the ouaba-
in-induced ROS generation. In experiments similar to those of
Fig. 1, ouabain was found to stimulate ROS generation in A7r5
cells (not shown) and in HeLa cells (Fig. 9). It is of particular
interest that the effective ouabain concentrations for ROS gen-
eration in HeLa cells are about two orders of magnitude lower
than the effective concentrations in rat cardiac myocytes (Fig.
FIG. 5. Time-dependent effects of 100 mM ouabain on tyrosine
phosphorylation of several proteins of myocytes incubated in
the Ca21-free medium. Myocytes cultured in the normal medium
were incubated in the Ca21-free medium for 15 min before being ex-
posed to ouabain for the indicated durations. Cell lysates were pre-
pared, and 60 mg of protein/lane was subjected to SDS-polyacrylamide
gel electrophoresis and immunoblotted with a monoclonal anti-phos-
photyrosine antibody as described under “Experimental Procedures”
and elsewhere (12). Quantitative comparisons of the intensities of three
prominent bands, with the indicated apparent kDa values, were also
done as previously described (12), using appropriate exposure times for
the different bands. The indicated values are mean 6 S.E. of four
independent experiments. The inset is a representative blot of three
prominent tyrosine-phosphorylated bands.
FIG. 6. Effects of genistein on ouabain-induced ROS produc-
tion. Myocytes cultured in the normal Ca21-containing medium were
preincubated with 100 mM genistein for 30 min, exposed to 100 mM
ouabain for 10 or 30 min, and then assayed for ROS as in Fig. 1. Each
value is the mean 6 S.E. of determinations from 30–40 cells in three
independent experiments. At each time point, values are expressed
relative to the control value of one at that time. *p , 0.05.
FIG. 7. Effect of the expression of the dominant negative Ras
on the ouabain-induced ROS production in cardiac myocytes.
Myocytes were transduced with either Ras Asn17 or a control virus for
12 h as indicated under “Experimental Procedures,” then exposed to
100 mM ouabain and assayed for ROS as in Fig. 1. Each value is the
mean 6 S.E. of 40–50 determinations in four independent experiments.
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9 and Ref. 11). This is in keeping with the established differ-
ences in the ouabain sensitivities of the predominant Na1/K1-
ATPase isoforms of these cells (2, 12).
In view of the findings of Fig. 9, limited experiments were
done to assess the possible relation of ouabain-induced ROS
generation in HeLa cells to [Ca21]i and [Na
1]i. As evident from
the data of Fig. 10, after 20 min of exposure of the cells to 0.1
mM ouabain in the normal Ca21-containing culture medium,
when a large increase in ROS was noted, there were no signif-
icant changes in [Na1]i and [Ca
21]i. These findings reinforce
the conclusions of the experiments on myocytes by showing
that, with ouabain concentrations that cause partial inhibition
of Na1/K1-ATPase, it is possible to induce ROS generation
without significant increases in [Ca21]i or [Na
1]i.
DISCUSSION
In our previous studies (7–12) we have shown that the
plasma membrane Na1/K1-ATPase of the cardiac myocyte acts
as a signal transducer by relaying the message of its interac-
tion with extracellular ouabain to the cell nucleus through
several interrelated pathways. We have also identified portions
of these pathways, including segments that are close to
ouabain’s interaction with the Na1/K1-ATPase and involve
Src, the epidermal growth factor receptor, and increased pro-
tein tyrosine phosphorylation. The findings presented here es-
tablish that such a proximal cascade that includes protein
tyrosine phosphorylation followed by the increased generation
of intracellular ROS, is independent of the increases in [Ca21]i
and [Na1]i that are the expected consequences of ouabain in-
teraction with the cardiac Na1/K1-ATPase. The logical conclu-
sion is that the Na1/K1-ATPase has two distinct roles within
the plasma membrane: One being its classical function as an
ion pump, and the other, as a signal transducer through pro-
tein-protein interactions. This and the other conclusions dis-
cussed below are summarized in Fig. 11.
Ouabain-induced Increases in ROS Generation and Protein
Tyrosine Phosphorylation Are Independent of Increases in
[Ca21]i and [Na
1]i—When myocytes are placed in a Ca
21-free
medium, there is no ouabain-induced increase in [Ca21]i (Figs.
2 and 3, and Table I), but there are ouabain-induced increases
in ROS generation and protein tyrosine phosphorylation (Figs.
1 and 5), which indicate that these events do not require the
ouabain-induced increase in [Ca21]i that is noted when myo-
cytes are in a Ca21-containing medium (Fig. 3 and Table I). The
irrelevance of the increase in [Na1]i to the above ouabain-
induced signaling events is also established convincingly by the
findings that, at the ouabain concentration used, with or with-
out the presence of extracellular Ca21, changes in [Na1]i are
nonexistent or barely detectable (Fig. 4) and by the lack of
effect of monensin on ROS production (Fig. 1). The data on
[Na1]i also suggest that a role for the altered [K
1]i is unlikely,
because any ouabain-induced change in [Na1]i is expected to be
accompanied by a smaller ouabain-induced change in [K1]i.
Taken together, the data of Table I and Figs. 1–5 show that, at
the ouabain concentrations used, the induced pathways leading
to increased protein tyrosine phosphorylation and ROS gener-
ation are parallel to those leading to a small increase in [Na1]i,
which in turn leads to a more prominent rise in [Ca21]i through
the altered function of the Na1/Ca21-exchanger (3–5) as de-
picted in Fig. 11.
Two other important aspects of the data of Table I and Figs.
1–5 need further consideration: 1) The highest ouabain concen-
tration (100 mM) we have used in the experiments on neonatal
rat cardiac myocytes to activate signal cascades does not affect
FIG. 8. Effects of DPI and myxothiazol on the ouabain-induced
ROS production in cardiac myocytes. Myocytes were pretreated
with either 20 mM DPI or 0.6 mM myxothiazol (MX) or the combination
of the two for 15 min then exposed to 100 mM ouabain. Intracellular ROS
were measured after 30 min of exposure to ouabain as in Fig. 1. Each
value, expressed relative to the control value of one in the absence of
ouabain, is the mean 6 S.E. of 40–50 determinations in four independ-
ent experiments. *p , 0.05 in comparison with control; **p , 0.05 in
comparison with ouabain-treated cells in the absence of DPI and MX.
FIG. 9. Dose-dependent effects of ouabain on the generation of
ROS in rat neonatal cardiac myocytes and HeLa cells. Cells were
exposed to the indicated concentrations of ouabain, and intracellular
ROS were measured as in Fig. 1 after 30 min of exposure. Each value,
expressed relative to the control value of one in the absence of ouabain,
is the mean 6 S.E. of 40–50 determinations in four independent exper-
iments. *p , 0.05; **p , 0.01.
FIG. 10. Effects of 0.1 mM ouabain on ROS generation, [Na1]i
and [Ca21]i in HeLa cells. Cells cultured in the normal Ca
21-contain-
ing medium were loaded with the appropriate fluorescent probes, ex-
posed to ouabain for 20 min, and assayed as indicated under “Experi-
mental Procedures.” Each value in the ouabain-treated cell population
is expressed relative to control value in cells not exposed to ouabain.
**p , 0.01. The calculated values of ion concentrations were: [Na1]i,
12.6 6 1.5 mM in the control and 13.7 6 3.9 mM in the presence of
ouabain; [Ca21]i, 71.7 6 5.7 nM in the control and 79 6 9 nM in the
presence of ouabain.
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myocyte viability (7) and causes about 50% inhibition of the
Na1/K1-ATPase activity and the associated transport function
in these cells (7, 24). At first, it may seem odd that this degree
of inhibition of the Na1/K1-ATPase leads to so little change in
the steady-state [Na1]i as shown in Fig. 4 and also noted
previously in neonatal rat cardiac myocytes (15). This apparent
discrepancy, which has been observed in various cardiac prep-
arations, is due to the well established reserve capacity of the
Na1/K1-ATPase with respect to the need for the maintenance
of normal Na1 and K1 gradients (4, 5, 18, 19). A number of
early studies have demonstrated that more than about 50%
inhibition of cardiac Na1/K1-ATPase by a cardiac glycoside is
required before significant changes in [Na1]i begin to occur (4,
5, 18). Interestingly, recent studies not involving cardiac gly-
cosides have also indicated the presence of an excess of Na1/
K1-ATPase in the rat heart by showing that the depression of
more than 40% of the enzyme content is needed before changes
in normal Na1 and K1 gradients are noted (25). The existence
of this excess capacity is also pertinent to the main conclusion
of the present work regarding the dual functions of the Na1/
K1-ATPase (Fig. 11), which suggests that the signal-transduc-
ing function of the enzyme through transient stimulus-induced
protein-protein interactions need not interfere with the house-
keeping function of the enzyme as an ion pump. 2) A number of
studies on the regulation of cardiac hypertrophy have sug-
gested that contraction per se may be a stimulus for the initi-
ation of the various gene regulatory signaling pathways (Ref.
17 and references therein). Our experiments on myocytes in
Ca21-free media (Figs. 1–5), showing ouabain-induced effects
on protein tyrosine phosphorylation and ROS production in
quiescent myocytes, also rule out contraction, or the altered
force of contraction, as the primary inducer of the signal path-
ways, at least for those segments that lead to ROS generation.
Our limited studies on cells other than cardiac myocytes
(Figs. 9 and 10, and Ref. 12) suggest that the entire pathway
that links Na1/K1-ATPase to ROS generation (Fig. 11) is not
limited to myocytes. Significantly, the findings on HeLa cells
(Fig. 10) strongly support the conclusions of the myocyte stud-
ies by showing ouabain-induced ROS generation in the absence
of increases in [Ca21 ]i and [Na
1]i. The ouabain concentration
used in these studies (0.1 mM) inhibits the hydrolytic and trans-
port functions of Na1/K1-ATPase of the wild-type HeLa cells by
about 40% (26). That [Ca21]i is not changed by ouabain (Fig.
10) is in keeping with the known absence of Na1/Ca21-ex-
changer in HeLa cells (27). The absence of a significant effect of
this concentration of ouabain on [Na1]i (Fig. 10) suggests that
HeLa cells, like myocytes, have an excess of Na1/K1-ATPase in
regard to the need for the maintenance of normal Na1 and K1
gradients. We know of no previous findings that argue for or
against the existence of such excess in HeLa cells.
The ROS-generating Pathway of Cardiac Myocytes Extends
from the Na1/K1-ATPase to the Mitochondria through Ras—
The blockade of ouabain-induced ROS production by genistein
(Fig. 6), coupled with the data on dominant negative Ras (Fig.
7), suggests that the Ras-dependent ROS generation is distal to
increases in protein tyrosine phosphorylation and the associ-
ated Src activation that are detailed in the accompanying paper
(12). Because in the absence of extracellular Ca21 the ouabain-
induced ROS generation persists (Fig. 1), but not the ouabain-
induced MAPK activation (10), we hypothesize two branches
beginning at Ras: one being the Ras/Raf/MEK/MAPK cascade,
and the other leading to ROS generation (Fig. 11). A possible
mechanism for the regulation of the Ras/MAPK cascade by rise
in [Ca21]i is an effect of a Ca
21/calmodulin-dependent protein
kinase on MEK, suggested in cells other than myocytes (28).
The partial inhibition of ouabain-induced ROS generation by
either myxothiazol or DPI and the complete inhibition by the
combination of the two (Fig. 8) are informative regarding the
sources of ROS. Myxothiazol is an inhibitor of the mitochon-
drial site III electron transport (29, 30), but DPI may block
ROS generation through the mitochondrial complex I or several
other cellular sources, including NAD(P)H oxidase (31). Our
data, therefore, implicate the mitochondria as a source of the
ouabain-induced ROS, but do not rule out other cellular
sources. Possible mechanisms for the extension of the ouabain-
induced pathways to the mitochondria include the Ras/ceram-
ide-mediated stimulation of the mitochondrial ROS generation,
for which there is evidence in cells other than cardiac myocytes
(32, 33). Regardless of the mechanistic details, the present
findings permit the important conclusion that signal pathways
initiated at Na1/K1-ATPase through protein-protein interac-
tions extend to the mitochondria to generate ROS.
Relation between [Ca21]i and ROS as Second Messengers—In
cardiac myocytes, and perhaps in all other cells that also ex-
press significant amounts of the plasma membrane Na1/Ca21-
exchanger, the most prominent early effect of the gradual in-
hibition of the Na1/K1-ATPase on intracellular ions is the rise
in [Ca21]i rather than changes in [Na
1]i and [K1]i (3–5, 18, 19).
With the partial inhibition of the enzyme, this increased
[Ca21]i, the source of which is the extracellular Ca
21, not only
regulates contractility, but also the growth and the gene regu-
latory effects that are associated with the partial inhibition of
Na1/K1-ATPase, as we have shown previously (7–10). The
present demonstration, that large segments of the proximal
signaling events emanating from Na1/K1-ATPase do not re-
quire the rise in [Ca21]i, clearly indicates that this rise is not an
early and all-important second messenger for the gene regula-
tory role of the cardiac Na1/K1-ATPase, but that it cooperates
with the increased ROS to regulate distal events and cross-talk
among the pathways (Fig. 11).
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